• español
    • English
    • português
  • English 
    • español
    • English
    • português
  • Login
Search 
  •   Home
  • Productos de Investigación - Creación
  • Search
  •   Home
  • Productos de Investigación - Creación
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.
RecursosRecursos de apoyo¿Cómo publicar?

Browse

All of ExpeditioCommunities & CollectionsBy Issue DateAuthorsTitlesSubjects
This CommunityBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Discover

AuthorNarang, Kavita (2)Abeykoon, Jithma (1)Ahlawat, Shruti (1)Altintas, Sevilay (1)Ambrosio, Giuseppe (1)Amjedi, Marjan (1)Asha (1)Astuti, Indwiani (1)Bai, Chen (1)Banu, Nehla (1)... View MoreSubject
ACE2 (34)
Coronavirus (34)COVID-19 (34)SARS-CoV-2 (34)
Síndrome respiratorio agudo grave (34)
Inflammation (3)Spike protein (3)TMPRSS2 (3)Cytokine storm (2)Diabetes (2)... View MoreHas File(s)Yes (32)No (2)
Estadísticas GTMVer Estadísticas GTM

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

Now showing items 1-10 of 34

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
Thumbnail

The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions 

Behl, Tapan; Kaur, Ishnoor; Bungau, Simona; Kumar, Arun; Uddin, Md Sahab; Kumar, Chanchal; Pa, Giridhari; Sahil; Shrivastava, Kamal; Zengin, Gokhan
The novel corona virus disease has shaken the entire world with its deadly effects and rapid transmission rates, posing a significant challenge to the healthcare authorities to develop suitable therapeutic solution to ...
Thumbnail

The integrin binding peptide, atn-161, as a novel therapy for SARS-CoV-2 infection 

Beddingfield, Brandon J.; Iwanaga, Naoki; Chapagain, Prem P.; Zheng, Wenshu; Roy, Chad J.; Hu, Tony Y.; Kolls, Jay K.; Bix, Gregory J.
Many efforts to design and screen therapeutics for the current severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic have focused on inhibiting viral host cell entry by disrupting ACE2 binding with the ...
Thumbnail

Immunological co-ordination between gut and lungs in SARS-CoV-2 infection 

Ahlawat, Shruti; Asha; Kant Sharma, Krishna
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved into a major pandemic called coronavirus disease 2019 (COVID-19) that has created unprecedented global health emergencies and emerged as a serious ...
Thumbnail

Does hereditary angioedema make COVID-19 worse? 

Xu, Yingyang; Liu, Shuang; Yan Zhang, Yan Zhang; Zhi, Yuxiang
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly worldwide. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for COVID-19, enters host cells via angiotensin-converting ...
Thumbnail

Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19) 

Huang, Yu-Feng; Bai, Chen; He, Fan; Xie, Ying; Zhou, Hua
The Coronavirus Disease 2019 (COVID-19) has been declared as a global pandemic, but specific medicines and vaccines are still being developed. In China, interventional therapies with traditional Chinese medicine for COVID-19 ...
Thumbnail

COVID-19 and Sex Differences: Mechanisms and Biomarkers 

Haitao, Tu; Vermunt, Jane; Abeykoon, Jithma; Ghamrawi, Ranine; Gunaratne, Madugodaralalage; Jayachandran, Muthuvel; Narang, Kavita; Parashuram, Santosh; Suvakov, Sonja; Garovic, Vesna
Men are consistently overrepresented in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, and COVID (COrona- VIrus-Disease)-19 severe outcomes, including higher fatality rates. These differences are ...
Thumbnail

ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19 

Dong, Mengzhen; Zhang, Jie; Ma, Xuefeng; Tan, Jie; Chen, Lizhen; Liu, Shousheng; Xin, Yongning; Zhuang, Likun
At the end of 2019, the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Currently, it is breaking out globally and posing a serious threat ...
Thumbnail

Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review 

Napoli, Claudio; Tritto, Isabella; Benincasa, Giuditta; Mansueto, Gelsomina; Ambrosio, Giuseppe
SARS-CoV-2 betacoronavirus is responsible for the Corona Virus Disease 2019 (COVID-19) which has relevant pathogenic implications for the cardiovascular system. Incidence and severity of COVID-19 are higher in the elderly ...
Thumbnail

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic 

Boettler, Tobias; Marjot, Thomas; Newsome, Philip N.; Mondelli, Mario U.; Maticic, Mojca; Cordero, Elisa; Jalan, Rajiv; Moreau, Richard; Cornberg, Markus; Berg, Thomas
During the early stages of the COVID-19 pandemic, EASL and ESCMID published a position paper to provide guidance for physicians involved in the care of patients with chronic liver disease. In the meantime, many countries ...
Thumbnail

Angiotensin converting enzyme-2 as therapeutic target in COVID-19 

Roshanravan, Neda; Ghaffari, Samad; Hedayati, Mehdi
  • 1
  • 2
  • 3
  • 4

Carrera 4 # 22-61 Teléfono: (+57 1) 242 7030 - 018000111022 Fax: (+57 1) 561 2107 Bogotá D.C., Colombia

Fundación Universitaria de Bogotá Jorge Tadeo Lozano | Vigilada Mineducación

Institución de educación superior privada, de utilidad común, sin ánimo de lucro y su carácter académico es el de Universidad.

Reconocimiento personería jurídica: Resolución 2613 del 14 de agosto de 1959 Minjusticia.

Institución de Educación Superior sujeta a inspección y vigilancia por el Ministerio de Educación Nacional.

 

Términos y condiciones | Políticas

 

 


Carrera 4 # 22-61 Teléfono: (+57 1) 242 7030 - 018000111022 Fax: (+57 1) 561 2107 Bogotá D.C., Colombia

Fundación Universitaria de Bogotá Jorge Tadeo Lozano | Vigilada Mineducación

Institución de educación superior privada, de utilidad común, sin ánimo de lucro y su carácter académico es el de Universidad.

Reconocimiento personería jurídica: Resolución 2613 del 14 de agosto de 1959 Minjusticia.

Institución de Educación Superior sujeta a inspección y vigilancia por el Ministerio de Educación Nacional.

 

Términos y condiciones | Políticas